Fit-for-Purpose COA Development: 25 years developing, modifying and validating PROs in more than 60 therapeutic categories. LEARN MORE

Translation Services: 25 years developing linguistically validated translations of COAs, CRFs, protocols, manuals, etc… READ MORE

QualityMetric By The Numbers: 53,000,000+ Global Survey administrations, 48,000+ Peer-reviewed articles across 100+ conditions, 200+ Language translations by mode of administrations, 100+ Condition-Specific, Country-Specific, and Insurance Claims Benchmarks General Population Norms. Which survey should you use? SEE OUR SUITE OF PRO SURVEYS

ePRO & EDC Integration: Seamless integration for optimal efficiencies using Web Service Application Programming Interface (API), Single Sign-on Access (SSO) or Electronic-Friendly Survey Administration. FIND OUT HOW


We're on a mission to advance migraine research by growing a powerful set of data based on your real experiences.

Get the HIT-6 Survey



HTANALYSTS and QualityMetric Partner to Provide Turn-key Outcome Measurement Solutions

Surry Hills, August 8th, 2022 — Leaders in Health Technology Assessment (HTA), impact evaluation and public health advisory services HTANALYSTS have just announced their official partnership with QualityMetric. QualityMetric has spent over three decades standardising functional health status assessments with patients, clinicians, caregivers, and health care professionals in mind. QualityMetric uses proprietary methodologies to capture, benchmark, and interpret health outcomes data.

HTANALYSTS has long been a trusted consultancy for the healthcare industry in Australia and New Zealand, having assisted with countless applications to list new and innovative health technologies and services on the PBS and MBS. And now HTANALYSTS adds to its plethora of offerings the tools and technology of QualityMetric.

CEO of HTANALYSTS Alasdair Godfrey said, “We have worked with QualityMetric for many years having both been formally member companies of Optum Life Sciences. We realise the power of their tools and know that, due to our shared history, this partnership is a perfect combination of world-leading technology and human-centric expertise.”

Over the last decade, the Australian healthcare industry has witnessed the growing need to capture the patient experience to better understand and respond to patient needs or to add real-world perspective to clinical trial evidence. Patient-reported outcomes (PRO) have never been so vital and informative. With Treasurer Dr Jim Chalmers announcing a budget that will include well-being considerations, the need for more inclusive human-centric data has expanded beyond the Department of Health’s purview.

However, capturing PRO can be challenging and requires tools to collect the information with integrity. With a wide variety of scientifically validated general health and disease-specific surveys, the tools offered by HTANALYSTS in partnership with QualityMetric provide all-inclusive, turn-key outcomes measurement solutions and the ability to customise. QualityMetric tools have the highest global use and set the standard in PRO and Clinical Outcomes Assessment (COA) measurement solutions.

Founder and CEO of QualityMetric, Gus Gardner added, “We are keen to formalize our business relationship with our colleagues at HTANALYSTS. After years of working side-by-side, we are looking for convergence; finding ways to work together to understand Health Outcomes and to help patients live healthier lives.”

To find out more about the exciting and powerful offerings from the HTANALYSTS and QualityMetric partnership, contact HTANALYSTS at:


Originally founded as Health Technology Analysts in 2002, HTANALYSTS has grown to become an industry leader, providing services to the healthcare industry. In HTANALYSTS 20 years, they have been providing boutique impact measurement and communication services, striving to make a powerful impact on society by driving human-centric outcomes. To learn more about HTANALYSTS visit:


QualityMetric works with the world’s leading healthcare and life sciences companies to measure and better understand outcomes through the creation, administration, and review of general and patient-specific health surveys. Founded in 1997, QM combines its proprietary scientifically validated general health and disease specific surveys with its enabling technology, advanced analytics, and sector expertise to work with all the world’s largest pharmaceutical companies in clinical trials and patient surveillance. For more information, please visit: